OpenResearchAlpha

Hepatology Communications · 20 Nov 2026

Immunosuppressive monocytes promote infection in patients with alcohol-associated hepatitis

Brett M. McGettigan, Shawna A. Cooper, Sofia Jerez, Dawood Al Dawood, Tejasav Sehrawat, Nidhi Jalan-Sakrikar, Laura Rogers, Harmeet Malhi, Enis Kostallari, Vijay H. Shah, and the TREAT investigators, AlcHepNet investigators

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
31
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • OpenAlex0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Background: Broad immune cell dysfunction known as immune paralysis is a hallmark of severe alcohol-associated hepatitis (AH). This process may drive susceptibility to infection and contribute to high short-term mortality in these patients. However, the mechanisms of immune paralysis are incompletely understood. The aim of this study was to elucidate the role of myeloid cells in immune dysfunction in severe AH to identify potential biomarkers of infection risk and therapeutic targets. Methods and Results: We analyzed the peripheral immune compartment of AH patients, heavy drinkers, and healthy controls and discovered that AH patients at risk for infection had an expanded peripheral monocyte population that was CXCR5 + CCR4 + (C-X-C chemokine receptor type 5, C-C chemokine receptor type 4) and had lower activity of pro-inflammatory pathways (eg, Tumor Necrosis Factor alpha, TNF-α, and Interleukin-1 beta, IL-1β) compared with controls. The frequency of circulating CXCR5 + CCR4 + monocytes in AH patients negatively correlated with 12-month transplant-free survival. Ex vivo CXCR5 + AH monocytes had reduced phagocytic activity, and they suppressed T-cell proliferation compared with CXCR5 − and healthy control monocytes. CXCR5 + AH monocytes expressed PD-L1 (Programmed Death Ligand 1), which is a costimulatory molecule known to inhibit T-cell activation, and TMEM176B (Tolerance-Related and Induced, TORID-1), which is an intracellular cation channel that regulates calcium flux. Inhibition of TORID-1 promoted human monocyte phagocytosis and IL-1β release. Conclusions: CXCR5 + CCR4 + monocytes arise in patients with severe AH and have impaired phagocytosis, reduced pro-inflammatory cytokine production, and suppress T-cell proliferation. These cells may promote susceptibility to bacterial infection and predict outcomes in severe AH. These may represent novel therapeutic targets to alleviate immune dysfunction in severe AH.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (11)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (31)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 11 more references

A free account opens the rest of the citing papers and references on every paper’s page.